Cross Country Healthcare buy melinda
Start price
05.09.12
/
50%
€3.54
Target price
05.03.13
€4.00
Performance (%)
23.42%
End price
05.03.13
€4.36
Summary
This prediction ended on 05.03.13 with a price of €4.36. The BUY prediction by melinda finished with a performance of 23.42%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cross Country Healthcare | 3.681% | 3.681% | -30.165% | -60.514% |
| iShares Core DAX® | -1,74 % | 5,98 % | 8,98 % | 49,86 % |
| iShares Nasdaq 100 | 2,81 % | 11,83 % | 38,41 % | 100,33 % |
| iShares Nikkei 225® | -0,11 % | 11,69 % | 46,68 % | 65,35 % |
| iShares S&P 500 | 0,97 % | 7,62 % | 28,14 % | 68,66 % |
Comments by melinda for this prediction
In the thread Cross Country Healthcare diskutieren
klinischen Studien
Langlauf und Gesundheitsdienstleister von klinischen Studien andere Dienste Human Capital Management konzentriert sich auf Gesundheits-
(Laufzeit überschritten)
Stopped prediction by melinda for Cross Country Healthcare
Cross Country Healthcare
Start price
Target price
Perf. (%)
€7.30
21.12.13
21.12.13
€5.50
23.06.14
23.06.14
-34.93%
23.06.14
23.06.14
